Mendelian Randomization and Infection: Pitfalls and Promises - Takeaways - MDSpire

Mendelian Randomization and Infection: Pitfalls and Promises

  • By

  • Fergus Hamilton

  • Guillaume Butler-Laporte

  • George Davey Smith

  • May 28, 2025

  • 0 min

Share

  • 1

    Mendelian randomization (MR) is a valuable tool in infectious disease research, aiding in causal inference where traditional methods fall short.

  • 2

    MR studies in infectious diseases have surged recently, but many violate core assumptions, leading to potentially invalid conclusions.

  • 3

    Using infection as an exposure in MR is particularly challenging due to limited genetic variants that reliably affect infection incidence.

  • 4

    Caution is needed when interpreting MR results, especially regarding genetic variants linked to antibody responses from infections or vaccinations.

  • 5

    Future MR applications in infectious diseases should focus on addressing causal questions that other methods cannot resolve.

Original Source(s)

Mendelian Randomization and Infection: Pitfalls and Promises

  • by Fergus Hamilton, Guillaume Butler-Laporte, George Davey Smith

  • May 28, 2025

Related Content

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.